FGFR2 and osteoporosis: observed increased miR-338-3p expression in an ovariectomy-induced rat osteoporosis model, reporting that miR-338-3p inhibited osteogenic differentiation by targeting both Runx2 and fibroblast growth factor receptor 2 (FGFR2) (52).